- Standing offer expands access to opioid overdose emergency treatment across participating federal, provincial and territorial organizations in Canada
WINNIPEG, Manitoba, Aug. 31, 2026 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) today announced that it has been awarded a standing offer by the Government of Canada, through a competitive procurement process, to supply NARCAN® Nasal Spray.
asserted
it → stand → Spray
The standing offer is effective from October 1, 2026, through September 30, 2029, with an option to extend for an additional two years.
asserted
offer → stand → years
Under the standing offer, authorized federal departments, agencies, Crown corporations, provinces, territories and other designated public sector organizations across Canada may procure NARCAN® Nasal Spray through individual call-ups, helping support timely access to overdose reversal medication in communities nationwide.
uncertain
departments → stand → communities
“Canada continues to face a significant public health challenge from the opioid crisis and expanding access to naloxone remains a critical component of overdose response efforts,” said Paul Williams, head of products business, global government & public affairs at Emergent.
asserted
Williams → continue → Emergent
“We are proud that the Government of Canada has selected NARCAN® Nasal Spray under this standing offer, reinforcing our commitment to helping to protect and save lives.”
asserted
Government → select → lives
NARCAN® Nasal Spray is designed to reverse the effects of an opioid poisoning in minutes and is the only 4 mg, intranasal naloxone spray in Canada with a shelf life of four years (48 months).
asserted
Spray → design → years
This award follows an existing 5-year standing offer between Emergent and the Government of Canada set to expire in September 2026.
asserted
award → follow → September
“As communities across Canada continue efforts to prevent opioid poisoning deaths, we remain focused on ensuring broad availability of NARCAN® Nasal Spray and supporting public health preparedness,” added Danielle Portnik, vice president and general manager at Emergent.
asserted
Portnik → continue → Emergent
“We appreciate the opportunity to continue working with the Government of Canada to improve access to this lifesaving treatment.”
asserted
We → appreciate → treatment
About NARCAN® Nasal Spray
NARCAN® Nasal Spray is a pure opioid antagonist indicated for emergency use to reverse known or suspected opioid overdose, as manifested by respiratory and/or severe central nervous system depression.
asserted
Spray → indicate → depression
While NARCAN® Nasal Spray can be administered by a non-health care professional, it is not intended to be a substitute for professional medical care.
asserted
it → administer → care
Always call 911 as soon as an opioid overdose is suspected, before administering NARCAN® Nasal Spray.
asserted
overdose → call → Spray
At Emergent, our mission is to protect and save lives.
asserted
mission → protect → lives
For over 25 years, we’ve been at work preparing those entrusted with protecting public health.
asserted
we → prepare → health
We deliver protective and life-saving solutions for health threats like smallpox, mpox, botulism, Ebola, anthrax and opioid overdose emergencies.
asserted
We → deliver → smallpox
To learn more about how we help prepare communities around the world for today’s health challenges and tomorrow’s threats, visit our website and follow us on LinkedIn, X, Instagram, Apple Podcasts and Spotify.
asserted
we → learn → LinkedIn
This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
asserted
release → include → 1995
All statements, other than statements of historical fact, including statements regarding the availability and Canadian government procurement of NARCAN® Nasal Spray are forward-looking statements.
asserted
statements → include → Spray
We generally identify forward-looking statements by using words like “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “forecast,” “goal,” “intend,” “may,” “plan,” “should,” “will,” “would,” and similar expressions or variations thereof, or the negative thereof, but these terms are not the exclusive means of identifying such statements.
uncertain
terms → identify → statements
Forward-looking statements are based on our current intentions, beliefs, and expectations regarding future events based on information that is currently available.
asserted
that → look → information
We cannot guarantee that any forward-looking statement will be accurate.
asserted
statement → guarantee → ?
Readers should realize that if underlying assumptions prove inaccurate or if known or unknown risks or uncertainties materialize, actual results could differ materially from our expectations.
uncertain
results → realize → expectations
Readers are, therefore, cautioned not to place undue reliance on any forward-looking statement.
asserted
Readers → caution → statement
Any forward-looking statement speaks only as of the date of this press release, and, except as required by law, we do not undertake to update any forward-looking statement to reflect new information, events, or circumstances.
asserted
we → look → information
Readers should consider this cautionary statement, as well as the risk factors identified in our periodic reports filed with the U.S. Securities and Exchange Commission, when evaluating our forward-looking statements.
asserted
Readers → consider → statements
The Aporia
